SCHEMBL28486284

SCHEMBL28486284

O=NC(=O)c1ccc2cnccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIPK2 Q9H2X6 1/20 0.53
SMYD3 Q9H7B4 2/20 0.48
CYP3A4 P08684 6/20 0.46
IMPDH2 P12268 3/20 0.44
KDM2B Q8NHM5 1/20 0.44
AKT1 P31749 3/20 0.43
AR P10275 1/20 0.43
HDAC3 O15379 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
FASN P49327 1/20 0.40
CDK2 P24941 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9750232 0.82 SMYD3 (0.45) HIPK2SMYD3CYP3A4IMPDH2KDM2B
SCHEMBL19900296 0.81 SMYD3 (0.44) HIPK2SMYD3CYP3A4IMPDH2KDM2B
SCHEMBL113378 0.80 SMYD3 (0.55) HIPK2SMYD3CYP3A4IMPDH2KDM2B
SCHEMBL29489099 0.80 SMYD3 (0.55) HIPK2SMYD3CYP3A4IMPDH2KDM2B
Hydrochloric Acid SCHEMBL7557776 0.79 SMYD3 (0.54) HIPK2SMYD3CYP3A4IMPDH2KDM2B
SCHEMBL4280154 0.79 AR (0.62) HIPK2SMYD3CYP3A4IMPDH2KDM2B
SCHEMBL29522657 0.79 AR (0.62) HIPK2SMYD3CYP3A4IMPDH2KDM2B
SCHEMBL3126130 0.79 IMPDH2 (0.53) HIPK2SMYD3CYP3A4IMPDH2KDM2B
SCHEMBL12765931 0.79 SMYD3 (0.50) HIPK2SMYD3CYP3A4IMPDH2KDM2B
SCHEMBL28437816 0.76 SMYD3 (0.58) SMYD3IMPDH2AKT1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114727950-A 1- (((2S,3S,4S) -3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl) methoxy) -7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms 辉瑞大药厂 2022-07-08 CN disclosed
CN-113423427-A IRAK degrading agents and uses thereof 凯麦拉医疗公司 2021-09-21 CN disclosed
CN-112105385-A IRAK degrading agents and uses thereof 凯麦拉医疗公司 2020-12-18 CN disclosed
CN-106458912-B Bicyclic fused heteroaryl or aryl compounds and their use as IRAK4 mimetics 辉瑞公司 2020-10-27 CN disclosed